Mitochondrial dynamics: General concepts and clinical implications

Neurology

Volumn 78, Issue 20, 2012, Pages 1612-1619

  Milone, Margherita ^a   Benarroch, Eduardo E ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; DYNAMIN I; EARLY GROWTH RESPONSE FACTOR 2; GLUTATHIONE TRANSFERASE; GUANOSINE TRIPHOSPHATE; MITOFUSIN 1; MITOFUSIN 2; PARKIN; GDAP PROTEIN; GUANOSINE TRIPHOSPHATASE; MFN2 PROTEIN, HUMAN; MITOCHONDRIAL PROTEIN; NERVE PROTEIN; OPA1 PROTEIN, HUMAN;

AMINO ACID SYNTHESIS; APOPTOSIS; ARTICLE; AUTOSOMAL DOMINANT OPTIC ATROPHY; CALCIUM HOMEOSTASIS; CORRELATION ANALYSIS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; FATTY ACID OXIDATION; GENE MUTATION; GENETIC ASSOCIATION; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; LEBER HEREDITARY OPTIC NEUROPATHY; MITOCHONDRION; MITOPHAGY; OXIDATIVE PHOSPHORYLATION; PARKINSON DISEASE; PRIORITY JOURNAL; STEROIDOGENESIS; ANIMAL; GENETICS; MEMBRANE FUSION; METABOLISM; MUTATION; NONLINEAR SYSTEM; PHYSIOLOGY; REVIEW;

ANIMALS; CHARCOT-MARIE-TOOTH DISEASE; GTP PHOSPHOHYDROLASES; HUMANS; MEMBRANE FUSION; MITOCHONDRIA; MITOCHONDRIAL DISEASES; MITOCHONDRIAL PROTEINS; MUTATION; NERVE TISSUE PROTEINS; NONLINEAR DYNAMICS;

EID: 84863598045     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3182563c46     Document Type: Article

References (48)

1. Chen H, Vermulst M, Wang YE, et al. Mitochondrial fusion is required for mtDNA stability in skeletal muscle and tolerance of mtDNA mutations. Cell 2010;141:280-289.
2. Novak I. Mitophagy: A complex mechanism of mitochondrial removal. Antioxid Redox Signal Epub 2011 Nov 12.
3. Schon EA, Przedborski S. Mitochondria: The next (neurode) generation. Neuron 2011;70:1033-1053.
4. Sheng ZH, Cai Q. Mitochondrial transport in neurons: Impact on synaptic homeostasis and neurodegeneration. Nat Rev Neurosci 2012;13:77-93.
5. Song Z, Chen H, Fiket M, Alexander C, Chan DC. OPA1 processing controls mitochondrial fusion and is regulated by mRNA splicing, membrane potential, and Yme1L. J Cell Biol 2007;178:749-755.
6. Otera H, Wang C, Cleland MM, et al. MFF is an essential factor for mitochondrial recruitment of Drp1 during mitochondrial fission in mammalian cells. J Cell Biol 2910; 191:1141-1158.
7. Niemann A, Wagner KM, Ruegg M, Suter U. GDAP1 mutations differ in their effects on mitochondrial dynamics and apoptosis depending on the mode of inheritance. Neurobiol Dis 2009;36:509-520.
8. Zhao J, Liu T, Jin S, et al. Human MIEF1 recruits Drp1 to mitochondrial outer membranes and promotes mitochondrial fusion rather than fission. Embo J 2011;30:2762-2778.
9. Cai Q, Sheng ZH. Mitochondrial transport and docking in axons. Exp Neurol 2009;218:257-267.
10. Wang X, Schwarz TL. The mechanism of Ca2+- dependent regulation of kinesin-mediated mitochondrial motility. Cell 2009;136:163-174.
11. Twig G, Shirihai OS. The interplay between mitochondrial dynamics and mitophagy. Antioxid Redox Signal 2011;14:1939 -1951.
12. Chu CT, Plowey ED, Dagda RK, Hickey RW, Cherra SJ 3rd, Clark RS. Autophagy in neurite injury and neurodegeneration: In vitro and in vivo models. Methods Enzymol 2009;453:217-249.
13. Meissner C, Lorenz H, Weihofen A, Selkoe DJ, Lemberg MK. The mitochondrial intramembrane protease PARL cleaves human Pink1 to regulate Pink1 trafficking. J Neurochem 2011;117:856-867.
14. Kawajiri S, Saiki S, Sato S, Hattori N. Genetic mutations and functions of PINK1. Trends Pharmacol Sci 2011;32: 573-580.
15. Geisler S, Holmstrom KM, Treis A, et al. The PINK1/ Parkin-mediated mitophagy is compromised by PDassociated mutations. Autophagy 2010;6:871-878.
16. Zuchner S, Mersiyanova IV, Muglia M, et al. Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot- Marie-Tooth neuropathy type 2A. Nat Genet 2004;36: 449-451.
17. Chung KW, Kim SB, Park KD, et al. Early onset severe and late-onset mild Charcot-Marie-Tooth disease with mitofusin 2 (MFN2) mutations. Brain 2006;129:2103-2118.
18. Verhoeven K, Claeys KG, Zuchner S, et al. MFN2 mutation distribution and genotype/phenotype correlation in Charcot- Marie-Tooth type 2. Brain 2006;129:2093-2102.
19. Feely SM, Laura M, Siskind CE, et al. MFN2 mutations cause severe phenotypes in most patients with CMT2A. Neurology 2011;76:1690-1696.
20. Klein CJ, Kimmel GW, Pittock SJ, et al. Large kindred evaluation of mitofusin 2 novel mutation, extremes of neurologic presentations, and preserved nerve mitochondria. Arch Neurol 2011;68:1295-1302.
21. Zhu D, Kennerson ML, Walizada G, Zuchner S, Vance JM, Nicholson GA. Charcot-Marie-Tooth with pyramidal signs is genetically heterogeneous: Families with and without MFN2 mutations. Neurology 2005;65:496-497.
22. Rouzier C, Bannwarth S, Chaussenot A, et al. The MFN2 gene is responsible for mitochondrial DNA instability and optic atrophy 'plus' phenotype. Brain Epub 2011 Dec 20.
23. Kijima K, Numakura C, Izumino H, et al. Mitochondrial GTPase mitofusin 2 mutation in Charcot-Marie-Tooth neuropathy type 2A. Hum Genet 2005;116:23-27.
24. Alexander C, Votruba M, Pesch UE, et al. OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat Genet 2000;26:211-215.
25. Amati-Bonneau P, Milea D, Bonneau D, et al. OPA1- associated disorders: Phenotypes and pathophysiology. Int J Biochem Cell Biol 2009;41:1855-1865.
26. Cornille K, Milea D, Amati-Bonneau P, et al. Reversible optic neuropathy with OPA1 exon 5b mutation. Ann Neurol 2008;63:667-671.
27. Milea D, Sander B, Wegener M, et al. Axonal loss occurs early in dominant optic atrophy. Acta Ophthalmol 2010; 88:342-346.
28. Davies VJ, Hollins AJ, Piechota MJ, et al. Opa1 deficiency in a mouse model of autosomal dominant optic atrophy impairs mitochondrial morphology, optic nerve structure and visual function. Hum Mol Genet 2007;16:1307-1318.
29. Amati-Bonneau P, Valentino ML, Reynier P, et al. OPA1 mutations induce mitochondrial DNA instability and optic atrophy 'plus' phenotypes. Brain 2008;131:338-351.
30. Hudson G, Amati-Bonneau P, Blakely EL, et al. Mutation of OPA1 causes dominant optic atrophy with external ophthalmoplegia, ataxia, deafness and multiple mitochondrial DNA deletions: A novel disorder of mtDNA maintenance. Brain 2008;131:329-337.
31. Yu-Wai-Man P, Griffiths PG, Gorman GS, et al. Multisystem neurological disease is common in patients with OPA1 mutations. Brain 2010;133:771-786.
32. Milone M, Younge BR, Wang J, Zhang S, Wong LJ. Mitochondrial disorder with OPA1 mutation lacking optic atrophy. Mitochondrion 2009;9:279-281.
33. Zanna C, Ghelli A, Porcelli AM, et al. OPA1 mutations associated with dominant optic atrophy impair oxidative phosphorylation and mitochondrial fusion. Brain 2008; 131:352-367.
34. Olichon A, Baricault L, Gas N, et al. Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrome c release and apoptosis. J Biol Chem 2003;278:7743-7746.
35. Baxter RV, Ben Othmane K, Rochelle JM, et al. Ganglioside-induced differentiation-associated protein-1 is mutant in Charcot-Marie-Tooth disease type 4A/8q21. Nat Genet 2002;30:21-22.
36. Cuesta A, Pedrola L, Sevilla T, et al. The gene encoding ganglioside-induced differentiation-associated protein 1 is mutated in axonal Charcot-Marie-Tooth type 4A disease. Nat Genet 2002;30:22-25.
37. Cassereau J, Chevrollier A, Gueguen N, et al. Mitochondrial complex I deficiency in GDAP1-related autosomal dominant Charcot-Marie-Tooth disease (CMT2K). Neurogenetics 2009;10:145-150.
38. Sevilla T, Cuesta A, Chumillas MJ, et al. Clinical, electrophysiological and morphological findings of Charcot-Marie- Tooth neuropathy with vocal cord palsy and mutations in the GDAP1 gene. Brain 2003;126:2023-2033.
39. Senderek J, Bergmann C, Ramaekers VT, et al. Mutations in the ganglioside-induced differentiation-associated protein-1 (GDAP1) gene in intermediate type autosomal recessive Charcot-Marie-Tooth neuropathy. Brain 2003; 126:642-649.
40. Zimon M, Baets J, Fabrizi GM, et al. Dominant GDAP1 mutations cause predominantly mild CMT phenotypes. Neurology 2011;77:540-548.
41. Waterham HR, Koster J, van Roermund CW, Mooyer PA, Wanders RJ, Leonard JV. A lethal defect of mitochondrial and peroxisomal fission.NEngl J Med 2007;356:1736-1741.
42. Song W, Chen J, Petrilli A, et al. Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity. Nat Med 2011;17:377-382.
43. Kitada T, Asakawa S, Hattori N, et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998;392:605-608.
44. Klein C, Djarmati A, Hedrich K, et al. PINK1, Parkin, and DJ-1 mutations in Italian patients with early-onset parkinsonism. Eur J Hum Genet 2005;13:1086-1093.
45. Kay DM, Moran D, Moses L, et al. Heterozygous parkin point mutations are as common in control subjects as in Parkinson's patients. Ann Neurol 2007;61:47-54.
46. Mortiboys H, Thomas KJ, Koopman WJ, et al. Mitochondrial function and morphology are impaired in parkinmutant fibroblasts. Ann Neurol 2008;64:555-565.
47. Valente EM, Salvi S, Ialongo T, et al. PINK1 mutations are associated with sporadic early-onset parkinsonism. Ann Neurol 2004;56:336-341.
48. Samaranch L, Lorenzo-Betancor O, Arbelo JM, et al. PINK1-linked parkinsonism is associated with Lewy body pathology. Brain 2010;133:1128-1142.